5:57 PM
 | 
Sep 20, 2013
 |  BC Extra  |  Company News

Japan approves Kadcyla, CHMP backs it

EMA's CHMP recommended approval of an MAA from Roche (SIX:ROG; OTCQX:RHHBY) and Japan approved an NDA from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) for Kadcyla ado-trastuzumab emtansine to treat HER2-positive breast cancer. The approval from Japan's Ministry...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >